IP Library › Granted Patent US 12,611,459
Granted Patent B2
US 12,611,459 · App. 17/616,552 · Granted Apr 28, 2026

System and method for unbinding of plasma protein-bound active agents using an ultrasound system

Inventors: Seung-Schik Yoo (Wellesley Hills, MA); Alexander Rotenberg (Brookline, MA)
Assignee: The Brigham and Women's Hospital, Inc.
A61K41/0028A61N7/02A61N2007/0021
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,611,459
App. No.
17/616,552
Granted
Apr 28, 2026
Kind
B2
Abstract

An ultrasound system for use in unbinding an active agent from a plasma protein in a target site in a subject includes a transducer configured to generate acoustic pressure waves and a controller coupled to the transducer. The controller is programmed to control the transducer to produce a plurality of pulsed acoustic pressure waves in the target site of the patient. The plurality of pulsed acoustic pressure waves disrupt a plasma protein binding between the active agent and the plasma protein within the target site. The disruption of the plasma protein binding causes an increase in an amount of unbound active agent in the target site.

Claims (22)

1 . An ultrasound system for use in unbinding an active agent from a plasma protein in a target site in a subject having 1) unbound active agent that is not bound to the plasma protein and 2) bound active agent comprising the active agent bound to the plasma protein, the ultrasound system comprising:

a transducer configured to generate acoustic pressure waves; and

a controller coupled to the transducer and programmed to control the transducer to produce a plurality of pulsed acoustic pressure waves in the target site of the subject the plurality of pulsed acoustic pressure waves having a set of parameters including an acoustic intensity configured to 1) disrupt a plasma protein binding between the active agent and the plasma protein of the bound active agent within the target site to cause an increase in an amount of unbound active agent in the target site, 2) ensure cavitation below a predetermined cavitation threshold, and 3) maintain a temperature of the target site below a predetermined temperature threshold.

2 . The ultrasound system according to claim 1 , wherein the controller is programmed to control the transducer to produce a focused plurality of pulsed acoustic pressure waves.

3 . The ultrasound system according to claim 1 , wherein the controller is programmed to control the transducer to produce an unfocused plurality of pulsed acoustic pressure waves.

4 . The ultrasound system according to claim 1 , wherein the set of parameters further includes at least one of a tone burst duration, a pulse repetition frequency, and a duty cycle.

5 . The ultrasound system according to claim 1 , wherein the acoustic intensity of the plurality of acoustic pressure waves is selected to produce a mechanical index (MI) below a predetermined MI threshold.

6 . The ultrasound system according to claim 1 , wherein the target site is a region of a brain.

7 . The ultrasound system according to claim 1 , wherein the plurality of pulsed acoustic pressure waves comprises one or more pulses having a tone burst duration in a range of 51 to 210 ms.

8 . The ultrasound system according to claim 1 , wherein the plurality of pulsed acoustic pressure waves comprises one or more pulses having a duty cycle in a range of 21% to 100%.

9 . The ultrasound system according to claim 6 , wherein the plurality of pulsed acoustic pressure waves comprises one or more pulses having a frequency between 100 kHz and 750 kHz.

10 . A method for unbinding an active agent from a plasma protein in a target site in a subject using an ultrasound system having a transducer and a controller, the target site having 1) unbound active agent that is not bound to the plasma protein and 2) bound active agent comprising the active agent bound to the plasma protein, the method comprising:

determining, using the controller, a set of parameters for a plurality of pulsed acoustic pressure waves including an acoustic intensity configured to 1) disrupt a plasma protein binding between the active agent and the plasma protein of the bound active agent within the target site to cause an increase in an amount of unbound active agent in the target site; 2) ensure cavitation below a predetermined cavitation threshold, and 3) maintain a temperature of the target site below a predetermined temperature threshold; and

generating, using the transducer, the plurality of pulsed acoustic pressure waves in the target site of the subject.

11 . The method according to claim 10 , wherein generating the plurality of pulsed acoustic pressure waves includes generating a focused plurality of pulsed acoustic pressure waves.

12 . The method according to claim 10 , wherein generating the plurality of pulsed acoustic pressure waves includes generating an unfocused plurality of pulsed acoustic pressure waves.

13 . The method according to claim 10 , wherein determining the set of parameters includes determining a frequency of the plurality of pulsed acoustic pressures waves in a range 100 kHz to 750 kHz based on the target site.

14 . The method according to claim 10 , wherein determining the set of parameters includes determining the acoustic intensity of the plurality of pulsed acoustic pressures waves to produce a mechanical index (MI) below a predetermined MI threshold.

15 . The method according to claim 14 , wherein determining the set of parameters includes selecting a tone burst duration for at least one pulse in the plurality of pulsed acoustic pressure waves from a range 51 to 210 ms.

16 . The method according to claim 15 , wherein determining the set of parameters includes selecting a duty cycle for at least one pulse in the plurality of pulsed acoustic pressure waves from a range 21% to 100%.

17 . The method according to claim 16 , wherein determining the set of parameters includes adjusting at least one of the parameters in the set of parameters until estimated or measured thermal effects are below a predetermined threshold.

18 . The method according to claim 10 , wherein the target site is a region of a brain.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 3, 2021
From: YOO, SEUNG SCHIK; ROTENBERG, ALEXANDER
To: THE BRIGHAM AND WOMEN'S HOSPITAL, INC.
Reel/Frame 058285/0458 →
Continuity (2)
Provisional Application 62857343 · Jun 5, 2019
Related Publication 20220233695A1 · Jul 28, 2022
References Cited (14)
US 20020090738A1 · Cozzette et al. · 2002 [cited by applicant]
US 20060264809A1 · Hansmann · 2006 [cited by examiner]
US 20110144566A1 · Dacey, Jr. et al. · 2011 [cited by applicant]
US 20110208021A1 · Goodall et al. · 2011 [cited by applicant]
US 20120174650A1 · Ariessohn et al. · 2012 [cited by applicant]
US 20120329082A1 · Viola et al. · 2012 [cited by applicant]
US 20210213307A1 · Kost · 2021 [cited by examiner]
J. Choi et al, “Noninvasive and localized blood-brain barrier disruption using focused ultrasound can be achieved at short pulse lengths and low pulse repetition frequencies”, Journal of Cerebral Blood Flow and Metaboli… [cited by examiner]
C. Mustafa et al, “Closed-loop cavitation control for focused ultrasound-mediated blood-brain-barrier opening by long-circulating microbubbles”, Physics in Medicine and Biology, pp. 1-27, 2018 (Year: 2018). [cited by examiner]
H. Kamimura et al, “Feedback control of microbubble cavitation for ultrasound-mediated blood-brain barrier disruption in non-human primates under magnetic resonance guidance”, Journal of Cerebral Blood Flow and Metaboli… [cited by examiner]
M. Burgess et al, “Power cavitation-guided blood-brain barrier opening with focused ultrasound and microbubbles”, Physics in Medicine and Biology, vol. 63, No. 6, p. 1-20, Mar. 2019 (Year: 2019). [cited by examiner]
V. Garbin et al, “Unbinding of targeted ultrasound contrast agent microbubbles by secondary acoustic forces”, Physics in Medicine and Biology, vol. 56, pp. 6161-6177, Aug. 2011 (Year: 2011). [cited by examiner]
“An Overview of the Biological Effects of Focused Ultrasound”, Jul. 2015 (Year: 2015). [cited by examiner]
International Search Report and Written Opinion of International Application No. PCT/US2020/036335, mailed Aug. 19, 2020, 9 pages. [cited by applicant]